AAME vs MET
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AAME is a StrongBuy and MET is a StrongBuy.
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
AAME’s FA Score shows that 0 FA rating(s) are green whileMET’s FA Score has 1 green FA rating(s).
- AAME’s FA Score: 0 green, 5 red.
- MET’s FA Score: 1 green, 4 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
MET’s TA Score shows that 6 TA indicator(s) are bullish.
- MET’s TA Score: 6 bullish, 4 bearish.
Price Growth
AAME (@Life/Health Insurance) experienced а +15.95% price change this week, while MET (@Life/Health Insurance) price change was +0.79% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was -0.01%. For the same industry, the average monthly price growth was +6.64%, and the average quarterly price growth was +2.02%.
Reported Earning Dates
AAME is expected to report earnings on Mar 25, 2025.
MET is expected to report earnings on Jul 30, 2025.
Industries' Descriptions
@Life/Health Insurance (-0.01% weekly)Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| AAME | MET | AAME / MET | |
| Capitalization | 57.1M | 53.3B | 0% |
| EBITDA | N/A | N/A | - |
| Gain YTD | 19.355 | -3.605 | -537% |
| P/E Ratio | 20.00 | 40.71 | 49% |
| Revenue | 185M | 66.4B | 0% |
| Total Cash | 24.3M | 308B | 0% |
| Total Debt | 36.8M | 18.8B | 0% |
AAME | MET | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 31 | 17 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 42 Fair valued | 41 Fair valued | |
PROFIT vs RISK RATING 1..100 | 100 | 16 | |
SMR RATING 1..100 | 90 | 99 | |
PRICE GROWTH RATING 1..100 | 40 | 48 | |
P/E GROWTH RATING 1..100 | 41 | 95 | |
SEASONALITY SCORE 1..100 | 50 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
MET's Valuation (41) in the Life Or Health Insurance industry is in the same range as AAME (42) in the Multi Line Insurance industry. This means that MET’s stock grew similarly to AAME’s over the last 12 months.
MET's Profit vs Risk Rating (16) in the Life Or Health Insurance industry is significantly better than the same rating for AAME (100) in the Multi Line Insurance industry. This means that MET’s stock grew significantly faster than AAME’s over the last 12 months.
AAME's SMR Rating (90) in the Multi Line Insurance industry is in the same range as MET (99) in the Life Or Health Insurance industry. This means that AAME’s stock grew similarly to MET’s over the last 12 months.
AAME's Price Growth Rating (40) in the Multi Line Insurance industry is in the same range as MET (48) in the Life Or Health Insurance industry. This means that AAME’s stock grew similarly to MET’s over the last 12 months.
AAME's P/E Growth Rating (41) in the Multi Line Insurance industry is somewhat better than the same rating for MET (95) in the Life Or Health Insurance industry. This means that AAME’s stock grew somewhat faster than MET’s over the last 12 months.
| MET | |
|---|---|
| RSI ODDS (%) | 2 days ago 65% |
| Stochastic ODDS (%) | 2 days ago 63% |
| Momentum ODDS (%) | 2 days ago 64% |
| MACD ODDS (%) | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 63% |
| TrendMonth ODDS (%) | 2 days ago 60% |
| Advances ODDS (%) | 2 days ago 67% |
| Declines ODDS (%) | 5 days ago 53% |
| BollingerBands ODDS (%) | 5 days ago 67% |
| Aroon ODDS (%) | 3 days ago 68% |
AAME and
Correlation & Price change
A.I.dvisor tells us that AAME and MET have been poorly correlated (+20% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AAME and MET's prices will move in lockstep.
| Ticker / NAME | Correlation To AAME | 1D Price Change % | ||
|---|---|---|---|---|
| AAME | 100% | +0.56% | ||
| MET - AAME | 20% Poorly correlated | +0.34% | ||
| PRU - AAME | 16% Poorly correlated | -0.02% | ||
| MFC - AAME | 15% Poorly correlated | -1.28% | ||
| AFL - AAME | 14% Poorly correlated | -0.31% | ||
| BHFAM - AAME | 14% Poorly correlated | -0.50% | ||
More | ||||